Wednesday, April 17, 2024
HomeFunding MA-based MitoSense Secures $3.5Million in Seed Funding

[Funding alert] MA-based MitoSense Secures $3.5Million in Seed Funding

MA-based MitoSense secures $3.5million in seed funding. Lead the funding round was Caydan Capital Partners. The funding will be used by the company to further its cutting-edge research in the field of mitochondrial organelle transplantation (MOTTM).

MA-based MitoSense secures $3.5million in seed funding. Lead the funding round was Caydan Capital Partners. The funding will be used by the company to further its cutting-edge research in the field of mitochondrial organelle transplantation (MOTTM).

MitoSense is a biotechnology business that focuses on developing treatments for neurodegenerative illnesses and is committed to improving mitochondrial health through novel therapeutics and research.

Read also – WA-based Oleria Secures $33.1M in Series A Round Funding

Numerous neurodegenerative illnesses, including Huntington’s, Parkinson’s, multiple sclerosis, and others, may be treated with this technology.

About MitoSense

MitoSense are a research and development firm that possesses patent-pending technology that is uniquely licenced. Their technique replenishes mitochondria to combat disease, especially neurological illnesses like Parkinson’s, Alzheimer’s, and ALS.

Read also – Conn.-based Kusari Secures $8m in Pre-Seed & Seed Funding

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular